Outcome of pediatric live-donor liver transplantation - The Toronto experience

被引:9
作者
Borenstein, S
Diamond, IR
Grant, DR
Greig, PD
Jones, N
Ng, V
Roberts, E
Fecteau, A
机构
[1] Hosp Sick Children, Div Gen Surg, Pediat Acad Multiorgan Transplant Program, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
liver transplantation; live donors; outcome; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; BILIARY COMPLICATIONS; CHILDREN; MANAGEMENT; CLOSURE;
D O I
10.1016/jpsu.2003.50179
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background/Purpose: Live-donor liver transplantation (LDLT) has developed to address the critical shortage of cadaveric organs that accounts for 20% of children who die while awaiting for a liver transplant in Ontario each year. This report reviews the outcome of the pediatric recipients of LDLT at the authors' center. Methods: The charts of all children who received a LDLT between June 1996 and March 2002 were reviewed retrospectively. Results: Thirteen children (mean age, 3.6 years) underwent LDLT. All donors were parents except for one cousin. Ten grafts were left-lateral segments, 2 were right lobes, and 1 was a left lobe. Three patients required a SILASTIC(R) (Dow Corning, Midland, MI) patch for delayed abdominal wall closure. Patient and graft survival rate was 100% with a median follow-up of 376 days. Major postoperative complications included biliary leaks (n = 2), biliary strictures In = 1), portal vein thrombosis (n = 1), and hepatic venous complications (n = 1). There were no cases of hepatic artery thrombosis. Ten of 12 children became Positive for Epstein-Barr virus (EBV), and 3 of these patients had readily treatable post-transplant lymphoproliferative disorder. Conclusions: LDLT is an acceptable alternative to cadaveric transplantation for children with end-stage liver disease.
引用
收藏
页码:668 / 671
页数:4
相关论文
共 27 条
[1]  
Adams M, 2000, LIVER TRANSPLANT, V6, P815
[2]  
BISMUTH H, 1984, SURGERY, V95, P367
[3]  
BISMUTH H, 1998, BRIT J SURG, V76, P722
[4]   LIVER-TRANSPLANTATION, INCLUDING THE CONCEPT OF REDUCED-SIZE LIVER-TRANSPLANTS IN CHILDREN [J].
BROELSCH, CE ;
EMOND, JC ;
THISTLETHWAITE, JR ;
WHITINGTON, PF ;
ZUCKER, AR ;
BAKER, AL ;
ARAN, PF ;
ROUCH, DA ;
LICHTOR, JL .
ANNALS OF SURGERY, 1988, 208 (04) :410-420
[5]   Long-term outcome after liver transplantation in children [J].
Bucuvalas, JC ;
Ryckman, FC .
PEDIATRIC TRANSPLANTATION, 2002, 6 (01) :30-36
[6]   Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients [J].
Cacciarelli, TV ;
Reyes, J ;
Jaffe, R ;
Mazariegos, GV ;
Jain, A ;
Fung, JJ ;
Green, M .
PEDIATRIC TRANSPLANTATION, 2001, 5 (05) :359-364
[7]  
Cheng YF, 1997, CLIN TRANSPLANT, V11, P337
[9]  
Egawa H, 1998, SURGERY, V124, P901, DOI 10.1067/msy.1998.91337
[10]  
Green M, 1999, Pediatr Transplant, V3, P271, DOI 10.1034/j.1399-3046.1999.00066.x